Unsere Publikationen

Change from platform to high efficacy disease-modifying treatment for multiple sclerosis despite NEDA

Link
https://doi.org/10.1016/j.nerep.2024.100211
Tags
Multiple SkleroseMS Behandlung
Jahr
2024
Autoren
Yalachkov Y, Akgün K, Ziemssen T.
Verlag
Neuroimmunology Reports. 2024, 5:100211.
Zum Eintrag

Rule-Based DSL for Continuous Features and ML Models Selection in Multiple Sclerosis Research

Link
https://doi.org/10.3390/app14146193
Tags
Multiple SkleroseManagement & ScienceeHealth
Jahr
2024
Autoren
Zhao W, Wendt K, Ziemssen T, Aßmann U.
Verlag
Applied Sciences. 2024; 14(14):6193.
Zum Eintrag

Real-world evidence from Germany and the United States: Treatment initiation on low-efficacy versus high-efficacy therapies in patients with multiple sclerosis

Link
https://doi.org/10.1016/j.msard.2024.105751
Tags
Multiple SkleroseMS BehandlungManagement & Science
Jahr
2024
Autoren
Papukchieva S, Kim HD, Stratil AS, Magurne E, Jonckheere A, Kahn M, Schneeweiss S, Ziemssen T, Friedrich B.
Verlag
Mult Scler Relat Disord. 2024 Jul 4;88:105751.
Zum Eintrag

Corticosteroid-depending effects on peripheral immune cell subsets vary according to disease modifying strategies in multiple sclerosis

Link
https://doi.org/10.3389/fimmu.2024.1404316
Tags
Multiple SkleroseMS Behandlung
Jahr
2024
Autoren
Höpner L, Proschmann U, Inojosa H, Ziemssen T, Akgün K.
Verlag
Front Immunol. 2024 Jun 13;15:1404316.
Zum Eintrag

Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing–Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study

Link
https://doi.org/10.1007/s40120-024-00637-2
Tags
Multiple SkleroseMS Behandlung
Jahr
2024
Autoren
Singer BA, Wray S, Gudesblatt M, Bumstead B, Ziemssen T, Bonnell A, Scaramozza M, Levin S, Shanmugasundaram M, Chen H, Mendoza JP, Lewin JB, Shankar SL.
Verlag
Neurol Ther. 2024 Jun 27.
Zum Eintrag

SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma

Link
https://doi.org/10.3390/vaccines12060684
Tags
Multiple SkleroseNeuroimmunologie
Jahr
2024
Autoren
Al Rahbani GK, Woopen C, Dunsche M, Proschmann U, Ziemssen T, Akgün K.
Verlag
Vaccines. 2024; 12(6):684.
Zum Eintrag

Using machine learning algorithms to detect fear of falling in people with multiple sclerosis in standardized gait analysis

Link
https://doi.org/10.1016/j.msard.2024.105721
Tags
Multiple SkleroseMobilitätManagement & Science
Jahr
2024
Autoren
Schumann P, Trentzsch K, Stölzer-Hutsch H, Jochim T, Scholz M, Malberg H, Ziemssen T.
Verlag
Mult Scler Relat Disord. 2024 Jun 10;88:105721.
Zum Eintrag

Challenges in monitoring the quality of care in multiple sclerosis—authors' reply

Link
https://doi.org/10.1016/j.lanepe.2024.100951
Tags
Multiple SkleroseMS BehandlungManagement & Science
Jahr
2024
Autoren
Voigt I, Fischer S, Proschmann U, Konofalska U, Richter P, Schlieter H, Berger T, Meuth SG, Hartung HP, Akgün K, Ziemssen T.
Verlag
The Lancet regional health. Europe, 2024, 42. Jg., S. 100951.
Zum Eintrag
1 2 3 4 5

Publikationen durchsuchen

Publikationen filtern

Filter
Tags
Multiple Sklerose
MS Behandlung
Mobilität
Autonomes Nervensystem & Neuroendokrinologie
Neuroimmunologie
Herzratenvariabilität
Baroreflexsensitivität
Management & Science
eHealth
Gesundheitsökonomie
Andere
Zeige alleVerstecke
Jahr
-